Management of corticosteroid-induced osteoporosis

Seminars in Arthritis and Rheumatism

Volumn 29, Issue 4, 2000, Pages 228-251

  Adachi, Jonathan D ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Olszynski, Wojciech P ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Hanley, David A ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Hodsman, Anthony B ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Kendler, David L ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Siminoski, Kerry G ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Brown, Jacques ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Cowden, Elizabeth A ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Goltzman, David ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Ioannidis, George ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Josse, Robert G ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Ste Marie, Louis Georges ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Tenenhouse, Alan M ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Davison, K Shawn ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Blocka, Ken L N ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Pollock, A Patrice ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Sibley, John ^{a,b,c,d,e,f,g,h,i,j,k,l,m}  

^a ST JOSEPH S HOSPITAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f Alba   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

^j ST MICHAEL'S HOSPITAL   (Canada)

^k CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^l UNIVERSITY OF SASKATCHEWAN   (Canada)

^m 501 25Charlton Ave e   (Canada)

more..

Author keywords

Bisphosphonates; Corticosteroid induced osteoporosis; Drug trials; Treatment options

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CLODRONIC ACID; CONJUGATED ESTROGEN; CORTICOSTEROID; ESTROGEN; ETIDRONIC ACID; FLUORIDE; NANDROLONE DECANOATE; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; RISEDRONIC ACID; TESTOSTERONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

BONE ATROPHY; BONE DENSITY; CLINICAL TRIAL; DRUG EFFICACY; HORMONE SUBSTITUTION; HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0033953232     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(00)80011-6     Document Type: Article

References (146)

1. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations Bull Johns Hopkins Hosp 50 1932 137 195
2. Sambrook P.N. Birmingham J. Kempler S. Kelly P. Eberl S. Pocock N. Corticosteroid effects on proximal femur bone loss J Bone Miner Res 5 1990 1211 1216
3. Baylink D.J. Glucocorticoid-induced osteoporosis N Engl J Med 309 1983 306 308
4. Adinoff A.D. Hollister J.R. Steroid-induced fractures and bone loss in patients with asthma N Engl J Med 309 1983 265 268
5. Lukert B.P. Raiaz L.G. Glucocorticoid-induced osteoporosis: pathogenesis and management Ann Intern Med 112 1990 352 364
6. Ruegsegger P. Medici T.C. Anliker M. Corticosteroid-induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computedtomography Eur J Clin Pharmacol 25 1983 615 620
7. Verstraeten A. Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dosecorticosteroids Ann Rheum Dis 45 1986 852 857
8. Gough A.K. Lilley J. Eyre S. Holder R.L. Emery E. Generalized bone loss in patients with early rheumatoid arthritis Lancet 344 1994 23 27
9. Bressot C. Meunier P.J. Chapuy M.C. Lejeune E. Edouard C. Darby A.J. Histomorphometric profile, pathophysiology and reversibility of corticosteroid induced osteoporosis Metab Bone Dis Rel Res 1 1979 303 311
10. Frost H.M. Villaneuva A.R. The effect of cortisone on lamellar osteoblastic activity Henry Ford Hosp Med J 9 1961 97 101
11. Dempster D.W. Arlot M.A. Meunier P.J. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis Calcif Tissue Int 35 1983 410 417
12. Ishida Y. Heersche J.N.M. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuateosteoblast differentiation J Bone Miner Res 13 1998 1822 1826
13. Peck W.A. Brand J. Miller I. Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro Proc Natl Acad Sci USA 57 1967 1599 1606
14. Caporali R. Gentile S. Caprotti M. Montecucco C. Serum osteocalcin (bone gla-protein) and steroid osteoporosis in rheumatoid arthritis J Rheumatol 18 1991 148 149
15. Godschalk M.F. Downs R.W. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men J Bone Miner Res 3 1988 113 115
16. Neilsen H.K. Thomsen K. Eriksen E.F. Charles P. Storm T. Moslcelide L. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects Bone Miner 4 1988 105 113
17. Prummel M.F. Wiersinga W.M. Lips P. Sanders G.T.B. Sauerwein H.P. The course of biochemical parameters of bone turnover during treatment with corticosteroids J Clin Endocrinol Metab 72 1991 382 386
18. Reid I.R. Chapman G.E. Fraser T.R.C. Davies A.D. Surus A.S. Meyer J. Low serum osteocalcin levels in glucocorticold-treated asthmatics J Clin Endocrinol Metab 62 1986 379 383
19. Kotowicz M.A. Hall S. Hunder G.G. Cedel S.L. Mann K.G. Riggs B.I. Relationship of glucocorticoid dosage to serum bone gla-protein concentration in patients with rheumatologic disorders Arthritis Rheum 33 1990 1487 1491
20. Eastell R. Reid D.M. Compston J. Cooper C. Fogelman I. Francis R.M. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update J Intem Med 244 1998 271 292
21. Stellon A.J. Webb A. Compston J.E. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis Gut 29 1988 378 384
22. Jee W.S.S. Park H.Z. Roberts W.E. Kenner G.H. Corticosteroids and bone Am J Anat 129 1970 477 479
23. Fucik R.F. Kukreja S.C. Hargis G.K. Bowser E.N. Henderson W.J. Williams G.A. Effect of glucocorticoids on function of the parathyroid glands in man J Clin Endocrinol Metabol 40 1975 152 155
24. Lukert B.P. Adams J.S. Calcium and phosphorus homeostasis in man: effect of corticosteroids Arch Intern Med 136 1976 1249 1253
25. Hahn T.J. Hahn B.H. Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy Semin Arthritis Rheum 6 1976 165 188
26. Hahn T.J. Halstead L.R. Teitelbaum S.L. Hahn B.H. Altered mineral metabolism in glucocorticoid induced osteopenia: effect of 25-hydroxyvitamin D administration J Clin Invest 64 1979 655 665
27. Seeman E. Dumar R. Hundar G.G. Scott M. Heath H. RiggS B.L. Production, degradation and circulating levels of 1,25-dihydroxyvitamin D in health and chronic glucocorticoid excess J Clin Invest 66 1980 664 669
28. Hahn T.J. Halstead L.R. Baran D.T. Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man J Clin Endocrinol Metab 52 1981 111 115
29. Klein R.G. Arnaud S.B. Gallagher J.C. Deluca H.F. Riggs B.L. Intestinal calcium absorption in exogenous hypercortisolism: role of 25-hydroxyvitamin D and corticosteroid dose J Clin Invest 60 1977 253 259
30. Kimberg D.V. Baerg R.D. Gershon E. Graudusius R.T. Effects of cortisone treatment on the active transport of calcium by the small intestine J Clin Invest 52 1973 1680 1685
31. Favus M.J. Walling M.W. Kimberg D.V. Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats J Clin Invest 52 1973 1680 1685
32. Suzuki Y. Ichikawa Y. Saito E. Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy Metabol 32 1983 151 156
33. Need A.G. Corticosteroids and osteoporosis Aust N Z J Med 17 1987 257 272
34. Reid I.R. Steroid osteoporosis Calcif Tissue Int 45 1989 63 67
35. Pearce G. Tabensky D.A. Delmas P.D. Baker H.W.G. Seeman E. Corticosteroid-induced bone loss in men J Clin Endocrinol Metab 83 1998 801 806
36. Jennings B.H. Andersson K.E. Johansson S.A. The assessment of the systemic effects of inhaled glucocorticosteroids: the effects of inhaled budesonide vs. oral prednisolone on calcium metabolism Eur J Clin Pharmacol 41 1991 11 16
37. Bikle D.D. Halloran B. Fong L. Steinbach L. Shellito J. Elevated 1,25-dihydroxyvitamin-D levels in patients with chronic obstructive pulmonary disease treated with prednisone J Clin Endocrinol Metab 76 1993 456 461
38. Williams G.A. Bowser E.N. Henderson W.J. Uzgiries V. Calcium absorption in the rat in relation to excessive vitamin D and cortisone Proc Soc Exp Biol Med 5 1960 354 358
39. Hahn T.J. Hastead L.R. Strates B. Imbimbo B. Baran D.T. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man Calcif Tissue Int 31 1980 109 115
40. Lekkerkerker I.F. Van Woudenberg F. Doorenbos H.D. Influence of low dose of sterol therapy on calcium absorption Acta Endocrinol (Copenh) 69 1972 488 496
41. (suppl) Sjoberg H.E. Retention of orally administered 47-calcium in man under normal diseased conditions studies with a wholebody counter technique Acta Med Scand 509 1970 1 28
42. 3 in patients on corticosteroid treatment and in patients with senile osteoporosis Acta Med Scand 204 1978 89 92
43. Adams J.S. Wahl T.O. Lukert B.P. Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients Metabol 30 1981 217 221
44. Findling J.W. Adams N.D. Lemann J. Gray R.W. Thomas C.J. Tyrrell J.B. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis J Clin Endocrinol Metab 52 1982 1680 1685
45. Lee D.B. Unanticipated stimulatory action of glucocorticoids on epithelial calcium absorption: effect of dexamethasone on rat distal colon J Clin Invest 71 1983 322 328
46. Binder H.T. Effect of dexamethasone on electrolyte transport in the large intestine of the rat Gastroenterology 75 1978 212 217
47. Ferretti J.L. Baran J.L. Alloatti D. Puche R.C. The intestinal handling of calcium by the rat in vivo, as affected by cortisol: effect of dietary calcium supplements Calcif Tissue Res 251 1978 1 6
48. Hahn T.J. Halstead L.R. Haddad J.G. Jr Serum 25 hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy J Lab Clin Med 90 1977 399 404
49. 3 in children receiving glucocordeoids Lancet ii 1978 1123 1125
50. Godschalk M. Levy J. Downs R.W. Glucocorticoids decrease vitamin D receptor numbers and gene expression in human osteosarcoma cells J Bone Miner Res 7 1992 21 27
51. Sakakura M. Takebe K. Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects J Clin Endocrinol Metab 40 1975 774 779
52. Luton J.P. Thieblot P. Valcke J.C. Mahoudeau J.A. Bricaire H. Reversible gonadotrophin deficiency in male Cushing's disease J Clin Endocrinol Metab 45 1977 488 495
53. Hsueh A.J. Erickson G.E. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells Steroids 32 1978 639 648
54. Doerr P. Pirke K.M. Cortisol-induced suppression of plasma testosterone in normal adult males J Clin Endocrinol Metab 43 1976 622 629
55. Schaison G. Durand F. Mowszowicz I. Effect of glucocorticoids on plasma testosterone in men Acta Endocrinol (Copenh) 89 1987 126 131
56. MacAdams M.R. White R.H. Chipps B.E. Reduction of serum testosterone levels during chronic glucocorticoid therapy Ann Intern Med 104 1986 648 651
57. Montecucco C. Caporalli R. Caprotti R. Notario A. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids J Rheumatol 19 1992 1895 1990
58. Goulding A. Gold E. Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving Bestradiol Endocrinology 122 1988 482 487
59. Hahn T.J. Boiseau V.C. Avioli L.V. Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass J Clin Endocrinol Metab 39 1974 274 282
60. Maldague B. Malghem J. de Deauxchaisnes C.N. Radiologic aspects of glucocorfcoid-induced bone disease Adv Exp Med Biol 171 1984 155 190
61. Saito J.K. Davis J.W. Wasnich R.D. Ross P.D. Users of low-dose glucocorticoids have increased bone loss rates: a longitudinal study Calcif Tissue Int 57 1995 115 119
62. Gennari C. Glucocorticoids and bone Peck W.A. Bone and Mineral Research/3 1985 Elsevier Amsterdam 213 232
63. Adachi J.D. Bensen W.G. Bell M.J. Corticosteroid induced osteoporosis: follow-up over 3 years Christiansen C. Overgaard K. Osteoporosis 1990 (3), Third International Symposium on Osteoporosis Copenhagen, Denmark 1990 1745 1747
64. Aman S. Hakala M. Silvennoinen J. Manelius J. Risteli L. Risteli J. Low incidence of osteoporosis in a two year follow-up of early community based patients with rheumatoid arthritis Scand J Rheumatol 27 1998 188 193
65. Kroger H. Honkanen R. Saarikoski S. Alhava E. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis: a population based study Ann Rheum Dis 53 1994 18 23
66. Sambrook P.N. Eisman J.A. Champion G.D. Yeates M.G. Pocock N.A. Eberl S. Determinants of axial bone loss in rheumatoid arthritis Arthritis Rheum 30 1987 721 728
67. Flicker L. Hopper J.L. Rodgers L. Kaymakci B. Green R.M. Wark J.D. Bone density determinants in elderly women: a twin study J Bone Miner Res 10 1995 1607 1613
68. Arden N.K. Baker J. Hogg C. Baan K. Spector T.D. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins J Bone Miner Res 11 1996 530 534
69. Morrison D. Capewell S. Reynolds S.P. Thomas J. Ali N.J. Read G.F. Testosterone levels during systemic and inhaled corticosteroid therapy Respir Med 88 1994 659 663
70. Ross P.D. Davis J.W. Epstein R.S. Wasnich R.D. Preexisting fractures and bone mass predict vertebral fracture incidence in women Ann Intern Med 114 1991 919 923
71. Kimble R.B. Alcohol, cytokines, and estrogen in the control of bone remodeling Alcohol Clin Exp Res 21 1997 385 391
72. Klein R.E. Alcohol-induced bone disease: impact of ethanol on osteoblast proliferation Alcohol Clin Exp Res 21 1997 329 392
73. Ernst E. Exercise for female osteoporosis: a systematic review of randomized clinical trials Sports Med 25 1998 359 368
74. Kano K. Relationship between exercise and bone mineral density among over 5,000 women aged 40 years and above J Epidemiol 8 1998 28 32
75. Egger P. Duggleby S. Hobbs R. Fall C. Cooper C. Cigarette smoking and bone mineral density in the elderly J Epidemiol Commun Health 50 1996 47 50
76. Law M.R. Cheng R. Hackshaw A.K. Allaway S. Hale A.K. Cigarette smoking, sex hormones and bone density in women Eur J Epidemiol 13 1997 553 558
77. Nielsen H.K. Charles P. Moskelide L. The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects J Clin Endocrinol Metab 67 1988 1025 1030
78. Need A.G. Philcox J.C. Hartley T.F. Nordin B.E. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women Aust N Z J Med 16 1986 341 346
79. Garnero P. Weichung J.S. Gineyts E. Karpf D.B. Delmas P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporosic women in response to alendronate treatment J Clin Endocrinol Metabol 79 1994 1693 1700
80. Seeman E. Wagner H.W. Offord K.P. Kumar R. Johnson W.J. Riggs B.L. Differential effects of endocrine dysfunction on the axial and appendicular skeleton J Clin Invest 69 1982 1302 1309
81. Marshall D. Johnell O. Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporosis fractures Br Med J 312 1996 1254 1259
82. Luengo M. Picado C. Rio L.D. Guanabens N. Montserrat J.M. Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study Thorax 46 1991 803 806
83. Hough S. Teitelbaum S.L. Bergfeld M.A. Avioli L.V. Isolated skeletal involvement in Cushing's syndrome: response to therapy J Clin Endocrin Metab 52 1981 1033 1038
84. Riggs B.L. Jowsey J. Kelly P.S. Quantitative microradiographic study of bone remodelling in Cushing's syndrome Metabol 15 1966 773 780
85. Sheagren J.N. Jowsey J. Bird D.C. Gurton M.E. Jacobs J.B. Effect on bone growth of daily versus alternate day corticosteroid administration: an experimental study J Lab Clin Med 89 1977 120 130
86. Gluck O.S. Murphy W.A. Hahn T.J. Hahn B.J. Bone loss in adults receiving alternate day glucccorticoid therapy Arthritis Rheum 24 1981 892 898
87. Tucci J.R. Tonino R.P. Emkey R.D. Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis Am J Med 101 1996 488 501
88. Watts N.B. Harris S.T. Genant H.K. Wasnich D.R. Miller P.D. Jackson R.D. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis N Engl J Med 323 1990 73 79
89. Devogelaer J.P. Broll H. Correa-Rotter R. Cumming D.C. De Deuxchaisnes C.N. Geusens P. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women withosteoporosis Bone 18 1996 141 150
90. Liberman U.A. Weiss S.R. Broll J. Minne H.W. Quan H. Bell N.H. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis N Engl J Med 333 1995 1437 1443
91. Black D.M. Cummings S.R. Karpf D.B. Cauley J.A. Thompson D.E. Nevitt M.C. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1997 1535 1541
92. Storm T. Thamsborg G. Steiniche T. Genaut H.K. Sorensen O.H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis N Engl J Med 322 1990 1265 1271
93. (suppl) Amin S. LaValley M.P. Simms R.W. Felson D.T. A meta-analysis ranking efficacy of treatments for corticosteroid-induced osteoporosis (CSOP) Arthritis Rheum 41 1998 S137
94. Roux C. Oriente P. Laan R. Hughes R.A. Ittner J. Goemaere S. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss J Clin Endocrinol Metabol 83 1998 1128 1133
95. Adachi J.D. Bensen W.G. Brown J. Hanley D. Hodsman A. Josse R. Intermittent cyclical etidronate therapy in the prevention of corticosteroid-iuduced-osteoporosis N Engl J Med 337 1997 382 387
96. Wolfhagen F.H.J. vanButaren H.R. Denouden J.W. Hop W.C.J. van Leeuwen J.P.T.M. Schalm S.W. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis J Hepatol 26 1997 325 330
97. (suppl) Jenkins E.A. Walker-Bone K.E. Wood A. McCrae F.C. Cooper C. Cawley M.I.D. The prevention of corticosteroid induced osteoporosis with intermittent cyclical etidronate Bone 20 1997 103S
98. Skingle S.J. Crisp A.J. Increased bone density in patients on steroids with etidronate Lancet 344 1994 543 544
99. Mulder H. Struys A. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss Br J Rheumatol 33 1994 348 350
100. Cohen S. Levy R. Keller M. Sewell K.L. Boling E. Eusebio R. Risedronate prevents bone loss and decreases the risk of vertebral fractures in corticosteroid-induced osteoporosis Bone 23 1998 S595
101. Boutsen Y. Jamart J. Essenlinckx W. Stoffel M. Devogelaer J.P. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial Calcif Tissue Int 61 1997 266 271
102. Gonnelli S. Rottoli P. Cepollaro C. Pondrelli C. Cappiello V. Vagliasindi M. Prevention of corticosteroid-induced with alendronate in sarcoid patients Calcif Tissue Int 61 1997 382 385
103. Nordborg E. Schaufelberger C. Andersson R. Bosaeus I. Bengtsson B. The ineffectiveness of cyclical oral clodronate on bone mineral density in glucocorticoid-treated patients with giant cell arteritis J Intern Med 242 1997 367 371
104. Pitt P. Li F. Todd P. Webber D. Pack S. Moniz C. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 53 1998 351 356
105. Guesens P. Dequeker J. Vanhoof J. Stalmans R. Boonen S. Joly J. Cyclic etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment: a double-blind,randomized placebo controlled study Ann Rheum Dis 57 1998 724 727
106. Worth H. Stammen D. Keck E. Therapy of steroidinduced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate Am J Respir Crit Care Med 150 1994 394 397
107. Saag K.G. Emkey R. Schnitzer T.J. Brown J.P. Hawkins F. Goemaere S. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis N Engl J Med 339 1998 292 299
108. Saag K. Emkey R. Cividino A. Brown J. Goemaere S. Dumortier T. Effects of alendronate for two years and BMD and fractures in patients receiving glucocorticoids Bone 23 1998 S182
109. Reid D. Cohen S. Pack S. Chines A. Ethgen D. Risedronate is an effective and well-tolerated therapy in both the treatment and prevention of corticosteroid-induced osteoporosis Bone 23 1998 S402
110. Reid I.R. Alexander C.J. King A.R. Ibberton H.K. Prevention of steroid-induced osteoporosis with (3-amino-l-hydroxypropylidene)-1, 1-bisphosphonate (APD) Lancet 23 1988 143 146
111. Adachi J.D. Pack S. Chines A.A. Intermittent etidronate and corticosteroid-induced osteoporosis N Engl J Med 337 1997 1921
112. Lukert B.P. Johnson B.E. Robinson R.G. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss J Bone Miner Res 7 1992 1063 1069
113. Hall G.M. Daniels M. Doyle D.V. Spector T.D. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis treated with and without steroids Arthritis Rheum 37 1994 1499 1504
114. Delmas P.D. Bjarnason N.H. Mitlak B.H. Ravoux A. Shah A.S. Huster W.J. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women N Engl J Med 337 1997 1641 1647
115. Adachi J.D. Bensen W.G. Bell M.J. Bianchi F.A. Cividino A.A. Craig G.L. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis Br J Rheum 36 1997 255 259
116. Healy J.H. Paget S. Williams-Russo P. Szatrowski T.P. Schneider R. Spiera H. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica Calcif Tissue Int 58 1996 73 80
117. Sambrook P. Birmingham J. Kelly P. Kempler S. Nguyen T. Pocock N. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin N Engl J Med 328 1993 1747 1752
118. Kotaniemi A. Piirainen H. Paimela L. Leirisalo-Repo M. Uoti-Reilama K. Lahdentausta P. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy? J Rheumatol 23 1996 1875 1879
119. Luengo M. Pons F. Martinez de Osaba M.J. Picado C. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study Thorax 49 1994 1099 1102
120. Luengo M. Picado C. Del Rio L. Guanabens N. Montserrat J.M. Setoain J. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma Am Rev Respir Dis 142 1990 104 107
121. Ringe J.D. Welzel D. Salmon calcitonin in the therapy of corticosteroid-induced osteoporosis Eur J Clin Pharmacol 33 1987 35 39
122. Lems W.F. Jacobs J.W.G. Bijlsma J.W.J. Croone A. Haanen C.M. Houben H.H.M.L. Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis Osteoporos Int 7 1997 575 582
123. Lems W.F. Jacobs J.W.G. Bijlsma J.W.J. van Veen G.J.M. Houben H.H.M.L. Haanen H.C.M. Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis? Ann Rheum Dis 56 1997 357 363
124. Guaydier-Souquieres G. Kotzki P.O. Sabatier J.P. Basse-Cathalinat B. Loeb G. In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study Osteoporosis Int 6 1996 171 177
125. Rizzoli R. Bonjour J.P. Slosman D.O. Chevalley T. Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis Osteoporos Int 5 1995 39 46
126. Lane N.E. Sanchez S. Modin G.W. Genant H.K. Plerini E. Arnaud C.D. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis: results of a randomized controlled clinical trial J Clin Invest 102 1998 1627 1633
127. Reid I.R. Wattie D.J. Evans M.C. Stapleton J.P. Testosterone therapy in glucocorticoid-treated men Arch Intern Med 156 1996 1173 1177
128. Adami S. Fossaluzza V. Rossini M. Bertoldo F. Gatti D. Zamberlan N. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate Bone Miner 15 1992 72 78
129. Adachi J.D. Bensen W.G. Bianchi F. Cividino A. Pillersdorf S. Sebaldt R.J. Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis: a 3 year follow-up J Rheum 23 1996 995 1000
130. 3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis: a randomized, double-blind placebo controlled trial Ann Intern Med 125 1996 961 968
131. Bernstein C.N. Seeger L.L. Anton P.A. Artinian L. Geffrey S. Goodman W. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatorybowel disease: a pilot study Aliment Pharmacol Ther 10 1996 777 786
132. Bijlsma J.W. Raymakers J.A. Mosch C. Hoekstra A. Derksen R.H.W.M. Baart H. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia Clin Exp Rheumatol 6 1988 113 119
133. Dykman T.R. Haralson K.M. Gluck O.S. Murphy W.A. Teitelbaum S.L. Hahn T.J. Effect of oral 1,25-dihydoxy vitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases Arthritis Rheum 27 1984 1336 1343
134. Wasnich R.D. Davis J.W. He Y.F. Petrovich H. Ross P.D. A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women Osteoporos Int 5 1995 247 251
135. Alon U. Costanzo L.S. Chan J.C. Additive hypocalciuric effects of amiloride and hydrochlorothiazide in patients treated with calcitriol Miner Electrolyte Metab 10 1984 379 386
136. Condon J.R. Nassim J.R. Dent C.E. Hilb A. Stainthorpe E.M. Possible prevention and treatment of steroid-induced osteoporosis Postgrad Med J 54 1978 249 252
137. Federal Register Medicare program Medicare coverage of and payment for bone mass measurements: rules and regulations 63 1998 34320 34328
138. Shaw J.M. Snow C.M. Weighted vest exercise improves indices of fall risk in older women J Gerontol Biol Sci Med Sci 53 1998 1153 1158
139. Nelson M.E. Fiatarone M.A. Morganti C.M. Trice I. Greenberg R.A. Evans W.J. Effects of high-intensity strength training on multiple risk factors for osteoporosic fractures: a randomized controlled trial JAMA 272 1994 1909 1914
140. Hickson R.C. Davis J.R. Partial prevention of glucocorticoid-induced muscle atrophy by endurance training Am J Physiol 241 1981 E226 E232
141. Hickson R.C. Kurowski T.T. Andrews G.H. Capaccio J.A. Chatterton R.T.J. Glucocorticoid cytosol binding in exerciseinduced sparing of muscle atrophy J Appl Physiol 60 1986 1413 1419
142. Czerwinski S.M. Kurowsk T.G. O'Neill T.M. Hickson R.C. Initiating regular exercise protects against muscle atrophy from glucocorticoids J Appl Physiol 63 1987 1504 1510
143. Schwid S.R. Goodman A.D. Puzas J.E. McDermott M.P. Mattson D.H. Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis Arch Neurol 53 1996 753 757
144. Lems W.F. Gerrits M.I. Jacobs J.W. van V.R. van R.H. Bijlsma J.W. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis Ann Rheum Dis 55 1996 288 293
145. Lems W.F. Jacobs J.W. van den Brink H.R. van R.H. Bijlsma J.W. Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritis Br J Rheumatol 32 1993 787 789
146. van der Veen M.J. Bijlsma J.W. Effects of different regime of corticosteroid treatment on calcium and hone metabolism in rheumatoid arthritis Clin Rheumatol 11 1992 388 392